Summary
Background
We aimed to investigate whether the MELD-Na score has a predictive value for postoperative complications in non-cirrhotic gastric cancer patients undergoing gastrectomy.
Materials and methods
The non-cirrhotic patients who were diagnosed with gastric cancer and underwent gastrectomy in our center from December 2020 to June 2022 were enrolled. MELD-Na scores of all patients were calculated within 48 h before surgery. A cut-off value was calculated for the MELD-Na score and patients were divided into two groups with a score of ≤ 10 and > 10. Postoperative 30-day complications including bleeding, ileus, wound infection, intra-abdominal abscess, evisceration, obstruction, anastomosis leakage, and pulmonary and cardiac complications were recorded. Clavien–Dindo scores were calculated. Univariate and multivariate analyses were performed.
Results
A total of 159 patients were included in this study. In the patients with a score of more than 10, wound infection, postoperative bleeding, pulmonary complications, re-operation risk, and any complications were found to increase significantly. A positive correlation was found between the Clavien–Dindo score and the higher value of MELD-Na score (p = 0.046). Moreover, postoperative complications were significantly higher in patients with comorbidity and high pathologic stages (p = 0.002 and 0.044, respectively). Multivariate analysis showed that comorbidity and high MELD-Na score were independent risk factors for postoperative complications.
Conclusion
In this study, it was found that a higher value of MELD-Na score was an independent predictive factor for development of postoperative complications.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10353-023-00823-w/MediaObjects/10353_2023_823_Fig1_HTML.png)
Similar content being viewed by others
References
Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative group. Lancet. 1996;347:995–9.
Li QG, Li P, Tang D, Chen J, Wang DR. Impact of postoperative complications on long-term survival after radical resection for gastric cancer. World J Gastroenterol. 2013;19(25):4060–5.
Chen K, Mou YP, Xu XW, Cai JQ, Wu D, Pan Y, Zhang R‑C. Short-term surgical and long-term survival outcomes after laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer. BMC Gastroenterol. 2014;14(1):41.
Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsu**aka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Japan clinical oncology group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.
Zhang J, Jiang L, Zhu X. A novel nomogram for prediction of early postoperative complications of total gastrectomy for gastric cancer. Cancer Manag Res. 2021;13:7579–91.
Kassir R, Blanc P, Tibalbo LMB, Breton C, Lointier P. C‑Reactive protein and procalcitonin for the early detection of postoperative complications after sleeve gastrectomy: preliminary study in 97 patients. Surg Endosc. 2015;29:1439–44.
Sun F, Ge X, Liu Z, Du S, Ai S, Guan W. Postoperative C‑reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer. World J Surg Oncol. 2017; https://doi.org/10.1186/s12957-017-1258-5.
Shi B, Liu S, Chen J, Liu J, Luo Y, Long L, Lan Q, Zhang Y. Sarcopenia is associated with perioperative outcomes in gastric cancer patients undergoing gastrectomy. Ann Nutr Metab. 2019;75(4):213–22. https://doi.org/10.1159/000504283.
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71.
Upadhyay RK. Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids. 2015;2015:971453.
Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the atherosclerosis risk in communities study. Arterioscler Thromb Vasc Biol. 2014;34:1770–7.
Lin JP, O’Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, Yang S, Kronenberg F. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham heart study. Circulation. 2006;114:1476–81.
Lange EO, Jensen CC, Melton GB, Madoff RD, Kwaan MR. Relationship between model for end-stage liver disease score and 30-day outcomes for patients undergoing elective colorectal resections: an American college of surgeons-national surgical quality improvement program study. Dis Colon Rectum. 2015;58:494–501.
Hedrick TL, Swenson BR, Friel CM. Model for end-stage liver disease (MELD) in predicting postoperative mortality of patients undergoing colorectal surgery. Am Surg. 2013;79:347–52.
Al Abbas AI, Borrebach JD, Bellon J, Zureikat AH. Does preoperative MELD score predict adverse outcomes following pancreatic resection: an ACS NSQIP analysis. J Gastrointest Surg. 2020;24:2259–68.
Coakley KM, Sarasani S, Prasad T, Steele SR, Paquette I, Heniford BT, Bradley R, Davis BR. MELD-Na score as a predictor of anastomotic leak in elective colorectal surgery. J Surg Res. 2018;232:43–8.
Khachfe HH, Araji TZ, Nassereldine H, El-Asmar R, Baydoun HA, Hallal AH, Jamali FR. Preoperative MELD score predicts adverse outcomes following gastrectomy: An ACS NSQIP analysis. Am J Surg. 2022; https://doi.org/10.1016/j.amjsurg.2022.01.027.
Zielsdorf SM, Kubasiak JC, Janssen I, Myers JA, Luu MB. A NSQIP analysis of MELD and perioperative outcomes in general surgery. Am Surg. 2015;81(8):755–9.
Rudasill SE, Dipardo B, Sanaiha Y, Mardock AL, Cale M, Antonios JW, Khoury H, Benharash P. International normalized ratio (INR) is comparable to MELD in predicting mortality after cholecystectomy. Am Surg. 2019;85(10):1184–8.
Causey MW, Steele SR, Farris Z, Lyle DS, Beitler AL. An assessment of different scoring systems in cirrhotic patients undergoing nontransplant surgery. Am J Surg. 2012;203:589–93.
Causey MW, Nelson D, Johnson EK, Maykel J, Davis B, Rivadeneira DE, Champagne B, Steele SR. The impact of model for end-stage liver disease-na in predicting morbidity and mortality following elective colon cancer surgery irrespective of underlying liver disease. Am J Surg. 2014;207(4):520–6.
Schlosser KA, Kao AM, Zhang Y, Prasad T, Kasten KR, Davis BR, Heniford BT, Colavita PD. MELD-Na score associated with postoperative complications in hernia repair in non-cirrhotic patients. Hernia. 2019;23(1):51–9.
Wagner J, Garcia-Rodriguez V, Yu A, Dutra B, Bhatt A, Larson S, Farooq A. The model for end-stage liver disease-sodium score at admission is prognostic of Covid-19 disease severity. SN Compr Clin Med. 2020; https://doi.org/10.1007/s42399-020-00534-3.
Brisinda G, Chiarello MM, Crocco A, Adams NJ, Fransvea P, Vanella S. Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: a retrospective cohort study. World J Gastroenterol. 2022;28(3):381–98.
Tsekrekos A, Lovece A, Chrysikos D, Ndegwa N, Schizas D, Kumagai K, Rouvelas L. Impact of obesity on the outcomes after gastrectomy for gastric canser. Asian J Surg. 2022;45(1):15–26.
Author information
Authors and Affiliations
Contributions
O. Akay: study concept and design, literature research, clinical studies, data collection and analysis, statistical analysis, writing manuscript, final approval of the manuscript; M. Guler: clinical studies, data collection and analysis, statistical analysis, final approval of the manuscript; H. Sevik: literature research, clinical studies, final approval of the manuscript; I. Yildiz: literature research, data collection and analysis, final approval of the manuscript; M.M. Sevinc: data collection and analysis, final approval of the manuscript; A. Ari: clinical studies, data collection and analysis, final approval of the manuscript; U. Oguz Idiz: critical review, literature research, final approval of the manuscript; C. Tatar: critical review, study concept and design, literature research, clinical studies, data collection and analysis, statistical analysis, writing manuscript, final approval of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
O. Akay, M. Guler, H. Sevik, I. Yildiz, M.M. Sevinc, A. Ari, U.O. Idiz, and C. Tatar declare that they have no competing interests.
Ethical standards
The study started with the approval of the Ethics Committee of Health Sciences University Istanbul Training and Research Hospital with decision number 2630 on 25.12.2020. Informed consent forms were signed by all patients who were included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Akay, O., Guler, M., Sevik, H. et al. MELD-Na score is associated with postoperative complications in non-cirrhotic gastric cancer patients undergoing gastrectomy. Eur Surg (2023). https://doi.org/10.1007/s10353-023-00823-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10353-023-00823-w